Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
654
datasets available to search
ShareScore release 0.9.0
Dataset results
654 results for “estrogen receptor”
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer
GEO Series GSE64033. Homo sapiens. 65 samples. Type: Expression profiling by array.
The Androgen Receptor is a Tumor Suppressor in Estrogen Receptor Positive Breast Cancer [ZR-75-1 cell line Bicalutamide study ER ChIP-seq]
GEO Series GSE141582. Homo sapiens. 6 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
A CRISPR-Cas9 screen identifies essential CTCF anchor sites for Estrogen Receptor-driven breast cancer cell proliferation
GEO Series GSE124667. Homo sapiens. 28 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
ClinicalTrials.gov study NCT03497702. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study
ClinicalTrials.gov study NCT05596409. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT06072807. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Ea
ClinicalTrials.gov study NCT04961996. IPD Sharing: YES. Countries: 54. Publications: 0.
Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02089854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT01327781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
ClinicalTrials.gov study NCT07287098. IPD Sharing: YES. Countries: 5. Publications: 0.
Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
ClinicalTrials.gov study NCT01738152. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts
ClinicalTrials.gov study NCT02752893. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Therapy for Estrogen Receptor-Positive/Human Epidermal Growth Factor Re
ClinicalTrials.gov study NCT06964906. IPD Sharing: YES. Countries: 1. Publications: 0.
Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
ClinicalTrials.gov study NCT05541367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT01208779. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial
ClinicalTrials.gov study NCT07245316. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
ClinicalTrials.gov study NCT05730647. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Validation of [18F]FES for Imaging of Brain Estrogen Receptors
ClinicalTrials.gov study NCT01842217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography
ClinicalTrials.gov study NCT03266562. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Lo
ClinicalTrials.gov study NCT04546009. IPD Sharing: YES. Countries: 30. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.